Policy Digest — November 16, 2026

Introduction
Physician groups pressed Congress to put a Medicare pay fix in a year-end bill, the Senate health committee set a vote on the nominee to lead the Food and Drug Administration (FDA), and Democrats began sorting out how far to expand Medicare.

Weekly Spotlight

Physician Pay: What Doctors Want From a Year-End Bill

Medicare physician payment falls on Jan. 1 unless Congress acts in the lame-duck session. The 2027 conversion factor drops 2.31% for most clinicians and 1.83% for qualifying participants in advanced alternative payment models (Federal Register). The one-year 2.5% increase that Congress enacted for 2026 expires Dec. 31.

Where talks stand. Senate Finance Committee Chair Mike Crapo (R-Idaho) says lawmakers are “working on” Medicare physician pay reform as part of talks on a year-end bill but have not reached an agreement (Inside Health Policy).

The coalition’s four asks. The American Medical Association (AMA) and 61 other organizations wrote to congressional leaders Nov. 12 asking for four changes in any year-end package (AMA, Becker’s Hospital Review). First, extend the 2.5% update through 2027. Second, enact the Provider Reimbursement Stability Act, which would require the Centers for Medicare and Medicaid Services (CMS) to correct budget neutrality adjustments when actual service use differs substantially from its estimates. Third, delay for one year the payment reduction that applies when an office visit and certain procedures are furnished on the same day. Fourth, cap Merit-based Incentive Payment System (MIPS) penalties at 2%, down from as much as 9%, and require timely performance data. Signers include the American College of Cardiology, the Society of Thoracic Surgeons, and the Society for Cardiovascular Angiography and Interventions (coalition letter). The letter says more than 80 members of Congress urged CMS not to finalize the same-day reduction.

A longer list from medical groups. The Medical Group Management Association (MGMA), which also signed the coalition letter, sent its own priorities Nov. 9 (Inside Health Policy, MGMA). MGMA asks Congress to extend the 2.5% increase and to stop or delay the 20% same-day reduction. MGMA also asks Congress to extend three provisions that end Dec. 31: the 3.1% incentive payment for advanced alternative payment model participants, the freeze on the thresholds for qualifying as a participant, and the 1.0 floor on the work geographic practice cost index. Two bills round out the list: the RESULTS Act, to prevent clinical laboratory fee schedule cuts, and the Improving Seniors’ Timely Access to Care Act.

The calendar. Government funding expires Dec. 11. Sen. Patty Murray (D-Wash.), in line to chair the Senate Appropriations Committee, wants a short-term patch into January, when Democrats take control (Politico).

Tags: #PROVIDER #HOSPITAL #PAYER


From Savage Health Policy

The 2027 Payment Rules, Section by Section. Free on Request.

My section-by-section summaries of the final 2027 Medicare physician fee schedule and hospital outpatient rules are free on request. Each summary walks through the rule one section at a time: what the Centers for Medicare and Medicaid Services (CMS) finalized, with page references, and what the comment record shows on selected provisions.

Email me at csavage@shpconsulting.llc and I will send both.

Congress may still change the physician pay cut before Jan. 1, as this week’s Spotlight reports. For a read built around your codes, issues, and products, start at the Comment Intelligence page.


Centers for Medicare and Medicaid Services (CMS)

Prior Authorization: Testing Opens Ahead of a Jan. 1 Deadline

The Office of the National Coordinator for Health Information Technology (ONC) and CMS announced Nov. 12 a series of voluntary testing events for electronic prior authorization. Starting Jan. 1, Medicare Advantage, Medicaid managed care, Children’s Health Insurance Program, and federal exchange plans must support electronic prior authorization. The testing rounds run 10 to 12 weeks, and organizations must sign up by Nov. 20. Separately, Newsweek reports on the contractors in Medicare’s Wasteful and Inappropriate Service Reduction (WISeR) Model. The Government Accountability Office says the contractors receive a percentage of savings, calculated from requests that did not result in a paid claim.

Tags: #PAYER #PROVIDER #HOSPITAL

Medicaid Expansion: Four States to Watch After the Elections

Democratic governors-elect in Texas, Georgia, and Wisconsin made Medicaid expansion part of their campaigns, STAT reports, though Republicans still hold part of the legislatures in Texas and Georgia. A KFF analysis adds Kansas to the states to watch. KFF estimates that 2.6 million uninsured adults in the 10 non-expansion states could become eligible if their states expanded, nearly half of them in Texas.

Tags: #PAYER #PATIENT #HOSPITAL

Medicaid: A Warning on Children’s Coverage and a Senate Probe

A Center on Budget and Policy Priorities analysis finds that the Medicaid cuts in the 2025 reconciliation law target the Affordable Care Act (ACA) expansion group but will reach children and pregnant people. The analysis points to the rollback of the three-month retroactive eligibility period, and to work requirements and more frequent eligibility checks that put eligible people at risk of losing coverage. Senate Finance Committee ranking member Ron Wyden (D-Ore.) and other Democrats opened a probe of what they call a politically motivated administration campaign against state Medicaid agencies.

Center on Budget and Policy Priorities Inside Health Policy

Tags: #PATIENT #PAYER

Joint Replacement: 2,217 Hospitals Face a Mandatory Model in 2028

The Comprehensive Care for Joint Replacement Expanded (CJR-X) model covers hip, knee, and ankle replacement episodes in traditional Medicare starting Jan. 1, 2028. CMS finalized the model July 31, and 2,217 acute care hospitals were set to participate as of Sept. 30. Episodes run through 90 days after discharge. CMS projects $736 million in Medicare savings over five performance years. A Duke orthopedic surgeon preparing his system says most hospitals have not yet convened the people who need to plan for the model.

Becker’s Hospital Review

Tags: #HOSPITAL #PROVIDER

Also in CMS

CMS published the 2027 home health final rule Nov. 9, with a 2.1% payment update and a temporary 3.0% reduction to the base payment rate (Federal Register). CMS distributed the final 200 of the 1,000 Medicare-funded residency positions Congress created five years ago, and medical groups called for more (MedPage Today). Comments are due Nov. 23 on what counts as “reasonable and relevant” terms in contracts between Medicare Part D plans and pharmacies (Becker’s Hospital Review). The American Society of Anesthesiologists urged CMS to keep Medicare’s physician supervision requirement for nurse anesthetists, which CMS asks about in a proposed rule open for comment until Jan. 11 (Becker’s Hospital Review). At least 38 states plan to use Rural Health Transformation Program money on incentives for clinicians to practice in rural areas, and recipients must stay at least five years (KFF Health News). Eight states report that they have carved the outpatient drug benefit out of their Medicaid managed care contracts (National Academy for State Health Policy).

Tags: #ALL


Food and Drug Administration (FDA)

FDA Leadership: A Committee Vote, a Voucher Program in Doubt, and a Smaller Staff

The Senate Health, Education, Labor, and Pensions (HELP) Committee will vote Nov. 18 on Heidi Overton’s nomination to lead FDA. Chair Bill Cassidy (R-La.) scheduled the vote while saying he remains undecided, and one Republican vote against her could sink the nomination in committee if all Democrats oppose her. Republicans have a short window to confirm her before Democrats take control in January. Becker’s Hospital Review, citing Reuters, reports that FDA has shelved the Commissioner’s National Priority Voucher program, which former Commissioner Marty Makary launched in 2025 to cut review times to one to two months. The Department of Health and Human Services (HHS) says the pilot is ongoing. No drug has received a voucher since Makary left in May, and 12 of the 22 drugs that received vouchers have been approved. FDA’s drug and biologics centers had 1,343 fewer employees this September than in September 2024, and an attorney quoted by BioPharma Dive predicts that rebuilding the workforce could take a year or two.

Tags: #DRUG #DEVICE

User Fees: Riders Ahead

Drug industry stakeholders expect the new Democratic majority to use next year’s FDA user fee reauthorizations to pursue more oversight of agency staffing and spending and possibly to advance measures on generic and biosimilar competition. Rep. Jake Auchincloss (D-Mass.) is pitching his bipartisan Faster Clinical Trials Act to new and returning lawmakers as the framework for policy riders on the prescription drug user fee reauthorization.

Tags: #DRUG #DEVICE

Also in FDA

FDA is asking how sponsors can submit patient-level data when a marketing application relies on real-world evidence, with comments due Jan. 11 (Federal Register). The Biotechnology Innovation Organization released a seven-priority plan, BioAdvance, that calls for a White House Office of Biotechnology and more flexible requirements for starting first-in-human trials (BioPharma Dive).

Tags: #DRUG


Department of Health and Human Services (HHS)

Grantmaking: Democrats Target a White House Rule

Rep. Rosa DeLauro (D-Conn.), the likely next chair of the House Appropriations Committee, says blocking a proposed Office of Management and Budget rule will be among Democrats’ top priorities. The rule would give political appointees more control over grantmaking at HHS and other departments. Public health and scientific groups back the effort. National Institutes of Health Director Jay Bhattacharya acknowledged funding disruptions on Nov. 10 and pushed back on claims that a “rocky” period is driving young scientists out of the field.

Tags: #ALL

Preventive Services Task Force: Blanket Ethics Waivers

Federal officials granted blanket waivers to every member of the U.S. Preventive Services Task Force, STAT reports from documents it obtained. Two members own private medical practices that could profit if the panel recommends particular types of care. Other waived conflicts include stock holdings in pharmaceutical and medical device companies.

STAT (subscription)

Tags: #PROVIDER #PAYER #PATIENT

Also in HHS

The HHS Healthcare Advisory Committee approved Medicare Advantage recommendations Nov. 9, including stronger obligations for insurance brokers, better tools for comparing plans, and changes to overlapping federal payments for veterans (Inside Health Policy). A telehealth expert warned White House budget officials Nov. 12 that emergency rooms could be flooded with refill requests if the Drug Enforcement Administration lets remote prescribing flexibilities for controlled substances expire in December (Inside Health Policy). MedPage Today reports that the HHS vaccine task force missed the deadline for its report (MedPage Today). The New York Times reports on the effects of the government’s shutdown of the Pediatric Brain Tumor Consortium, which had operated for 27 years (The New York Times).

Tags: #ALL


Heard on the Hill

Medicare Expansion: New Benefits, Age 50, and Children

Democrats are weighing how far to expand public coverage. The incoming Democratic heads of both key Senate health committees, Sens. Ron Wyden and Bernie Sanders (I-Vt.), are interested in adding benefits to traditional Medicare as an incremental step. Sen. Tammy Baldwin (D-Wis.) announced Nov. 10 the Medicare at 50 Act, which would let people ages 50 to 64 buy into Medicare. STAT reports that “Medicare for More” is emerging as a consensus policy between the party’s moderate and liberal wings. Sen. Andy Kim’s (D-N.J.) MediKids bill would cover children and young adults up to age 26 by broadening Medicaid eligibility and enrolling newborns automatically. The Hill reports that Rep. Raul Ruiz (D-Calif.) called Medicare for All not a “realistic expectation” in the next Congress.

Tags: #PAYER #PATIENT

Democrats’ Agenda: Subsidies, Work Requirements, and Corporate Health Care

Rep. Richard Neal, the incoming House Ways and Means chair, told Bloomberg on Nov. 12 that Democrats plan to move quickly to revive the expired enhanced ACA subsidies and reverse Medicaid cuts. Sixteen Senate Democrats asked leadership Nov. 9 for a two-year delay of the Medicaid work requirements. On Nov. 13 the White House allowed states to delay the work rules by six months, KFF Health News reports. Axios reports that Democrats are uniting around attacks on corporate health care.

Tags: #PAYER #PATIENT #HOSPITAL

No Surprises Act: A Cassidy Bill, a Split Among Democrats, and Suits Against Employers

Outgoing Senate HELP Chair Bill Cassidy plans to release legislation soon on the No Surprises Act’s dispute resolution process, an aide said Nov. 12. The aide said the proposal would strengthen program integrity, improve oversight of arbiters, and increase transparency. Georgetown researchers say disputes are on track to exceed 4 million in 2026, up from 2.5 million in 2025. Rep. Raul Ruiz (D-Calif.), who has expressed interest in chairing the Energy and Commerce health subcommittee, said the arbitration process must be maintained. Rep. Frank Pallone (D-N.J.), expected to chair the full committee, has a bill that would end arbitration and set a benchmark based on median in-network rates. Air ambulance company PHI Health has sued hundreds of employers over unpaid out-of-network claims that it won in arbitration, STAT reports.

Tags: #PROVIDER #PAYER #HOSPITAL

Drug Pricing: Wyden Open to a Trade

Sen. Ron Wyden, the likely next Finance Committee chair, told reporters Nov. 9 that negotiation is “on the table” on a potential agreement to codify the administration’s most-favored-nation agreements with drugmakers in exchange for expanding the number of drugs that can be selected for Medicare price negotiation. The Association for Accessible Medicines sees an opening to work with the new majority on pharmacy benefit manager changes that increase use of generics and biosimilars. Democrats’ inquiry into those deals expanded to 27 companies in November, Becker’s Hospital Review reports.

Tags: #DRUG #PAYER

On the Hill

Republicans chose Rep. Jim Jordan (R-Ohio), a founder of the House Freedom Caucus, on Nov. 10 to lead the House Republican caucus through the next Congress. A day earlier the Freedom Caucus urged Republican leaders to use the lame duck to expand health savings accounts and codify short-term limited-duration plans through reconciliation (Inside Health Policy). Sen. Rand Paul (R-Ky.) said Nov. 11 that he is seeking the top Republican spot on the Senate HELP Committee (The Hill). Sens. Ron Wyden and Angela Alsobrooks (D-Md.) opened an investigation into whether HHS Secretary Robert F. Kennedy Jr. lied to Congress about the reason for a 2019 trip to Samoa (Associated Press via KFF Health News, Bloomberg). The House will consider a bipartisan bill that would let the Congressional Budget Office estimate the costs and savings of preventive health legislation over 30 years, up from 10 (Inside Health Policy).

Tags: #ALL


Notable Notes

AMA Interim Meeting: New Policies on Artificial Intelligence and Peptides

The AMA House of Delegates adopted policy Nov. 9 stating that artificial intelligence (AI) cannot be licensed or certified to practice medicine. The policy says vendors should be liable when a clinical AI product used as intended causes harm. The AMA also urged HHS, FDA, and other regulators to “immediately rescind” policies that loosen restrictions on compounding unapproved synthetic peptides. Modern Healthcare reports new AMA policies on pay and physician autonomy.

Tags: #PROVIDER #PAYER #DRUG

Aortic Valve Evidence: Five-Year Surgical Data and Moderate Stenosis

An observational study of patients ages 50 to 65 found that 87.5% of those who had surgical aortic valve replacement were free of death, stroke, valve reintervention, and heart failure rehospitalization at five years, against 77.8% of those who had transcatheter aortic valve replacement (TAVR). TAVR did better on in-hospital mortality and periprocedural stroke. The study, in The Annals of Thoracic Surgery, is a target trial emulation using real-world data, not a randomized trial. Separately, Philippe Généreux, global principal investigator of the PROGRESS trial, told Cardiovascular Business that moderate aortic stenosis “should not be seen anymore as a benign entity.” In PROGRESS, TAVR in select patients with moderate stenosis reduced a composite of death or heart failure events 33% at two years compared with clinical surveillance.

Tags: #DEVICE #PROVIDER

Congenital Heart Research

Maternal chronic hypertension was associated with higher odds of critical congenital heart disease (adjusted odds ratio 1.30) in a study of more than 40 million U.S. births presented at the American Heart Association Scientific Sessions. A 14-patient feasibility study found that eight weeks of voice lessons and choir rehearsals improved select breathing measures and self-reported wellbeing in children with single-ventricle heart disease. A third study, reported by Medical Xpress, links watching sports to fewer depressive symptoms in adults with congenital heart disease.

Tags: #PATIENT #PROVIDER

Also Notable

Duet, a nurse practitioner-owned primary care network, raised $15 million and plans to launch what it calls the first nurse practitioner-led Medicare accountable care organization in 2027 (Fierce Healthcare). An opinion piece argues that the next phase of the 340B program will turn on claims data, with a revised rebate pilot scheduled to begin in January 2027 (The Health Care Blog).

Tags: #ALL

Leave a Comment

Your email address will not be published. Required fields are marked *

Subscribe

Receive our Policy Digest in your email inbox each week.

Scroll to Top

Contact Us

Savage Health Policy
csavage@shpconsulting.llc
(276) 221-8300

Please provide your contact information below and we will reply to you shortly.

Contact Form